Cargando…

A Rich Array of Prostate Cancer Molecular Biomarkers: Opportunities and Challenges

Prostate cancer is the most prevalent non-skin cancer in men and is the leading cause of cancer-related death. Early detection of prostate cancer is largely determined by a widely used prostate specific antigen (PSA) blood test and biopsy is performed for definitive diagnosis. Prostate cancer is asy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kohaar, Indu, Petrovics, Gyorgy, Srivastava, Shiv
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6515282/ https://www.ncbi.nlm.nih.gov/pubmed/31013716 http://dx.doi.org/10.3390/ijms20081813

Ejemplares similares

Biomarkers of Aggressive Prostate Cancer at Diagnosis
por: Boehm, Brock E., et al.
Publicado: (2023)

Association of TP53 Single Nucleotide Polymorphisms with Prostate Cancer in a Racially Diverse Cohort of Men
por: Duncan, Allison, et al.
Publicado: (2023)

Long noncoding RNA-mediated activation of androgen receptor in prostate cancer
por: Petrovics, Gyorgy, et al.
Publicado: (2014)

Prostate Cancer Genomics: Recent Advances and the Prevailing Underrepresentation from Racial and Ethnic Minorities
por: Tan, Shyh-Han, et al.
Publicado: (2018)

Association of germline genetic variants with TMPRSS2-ERG fusion status in prostate cancer
por: Kohaar, Indu, et al.
Publicado: (2020)

Genetic and Molecular Differences in Prostate Carcinogenesis between African American and Caucasian American Men
por: Farrell, James, et al.
Publicado: (2013)

Oncogenic activation of ERG: A predominant mechanism in prostate cancer
por: Sreenath, Taduru L, et al.
Publicado: (2011)

Biomarkers for prostate cancer: present challenges and future opportunities
por: Sharma, Pranav, et al.
Publicado: (2015)

Loss of miR-449a in ERG-associated prostate cancer promotes the invasive phenotype by inducing SIRT1
por: Kumar, Parameet, et al.
Publicado: (2016)

Derivation and Application of Molecular Signatures to Prostate Cancer: Opportunities and Challenges
por: Doultsinos, Dimitrios, et al.
Publicado: (2021)

Increased frequency of germline BRCA2 mutations associates with prostate cancer metastasis in a racially diverse patient population
por: Petrovics, Gyorgy, et al.
Publicado: (2018)

Loss of the NKX3.1 tumorsuppressor promotes the TMPRSS2-ERG fusion gene expression in prostate cancer
por: Thangapazham, Rajesh, et al.
Publicado: (2014)

Molecular profiling of radical prostatectomy tissue from patients with no sign of progression identifies ERG as the strongest independent predictor of recurrence
por: Yan, Wusheng, et al.
Publicado: (2019)

Low Frequency of the ERG Oncogene Alterations in Prostate Cancer Patients from India
por: Rawal, Sudhir, et al.
Publicado: (2013)

Germline mutation landscape of DNA damage repair genes in African Americans with prostate cancer highlights potentially targetable RAD genes
por: Kohaar, Indu, et al.
Publicado: (2022)

Proton Therapy for Prostate Cancer: Challenges and Opportunities
por: Poon, Darren M. C., et al.
Publicado: (2022)

Bioimaging of Dissolvable Microneedle Arrays: Challenges and Opportunities
por: Wang, Yanni, et al.
Publicado: (2022)

Prostate cancer marker panel with single cell sensitivity in urine
por: Nickens, Kristen P., et al.
Publicado: (2015)

PMEPA1 Gene Isoforms: A Potential Biomarker and Therapeutic Target in Prostate Cancer
por: Sharad, Shashwat, et al.
Publicado: (2020)

A novel genomic alteration of LSAMP associates with aggressive prostate cancer in African American men
por: Petrovics, Gyorgy, et al.
Publicado: (2015)

Functional antagonism of TMPRSS2-ERG splice variants in prostate cancer
por: Rastogi, Anshu, et al.
Publicado: (2014)

Prostate cancer gene expression signature of patients with high body mass index
por: Sharad, Shashwat, et al.
Publicado: (2010)

Aquaporins as Prognostic Biomarker in Prostate Cancer
por: Kushwaha, Prem Prakash, et al.
Publicado: (2023)

Prostate stem cell antigen (PSCA) and risk of bladder cancer: linking genotypes to functional mechanisms
por: Mumy, Adam, et al.
Publicado: (2011)

Extracellular vesicles as circulating cancer biomarkers: opportunities and challenges
por: Lane, R. E., et al.
Publicado: (2018)

Multi-omic serum biomarkers for prognosis of disease progression in prostate cancer
por: Kiebish, Michael A., et al.
Publicado: (2020)

Silencing of PMEPA1 accelerates the growth of prostate cancer cells through AR, NEDD4 and PTEN
por: Li, Hua, et al.
Publicado: (2015)

Opportunities and challenges of circulating biomarkers in neuroblastoma
por: Trigg, Ricky M., et al.
Publicado: (2019)

MicroRNAs as Potential Biomarkers in Cancer: Opportunities and Challenges
por: Lan, Huiyin, et al.
Publicado: (2015)

Methylation of the PMEPA1 gene, a negative regulator of the androgen receptor in prostate cancer
por: Sharad, Shashwat, et al.
Publicado: (2014)

Exosomal circRNAs as novel cancer biomarkers: Challenges and opportunities
por: Wang, Shuai, et al.
Publicado: (2021)

Quantitative Expression of TMPRSS2 Transcript in Prostate Tumor Cells Reflects TMPRSS2-ERG Fusion Status
por: Mwamukonda, Kuwong, et al.
Publicado: (2009)

Blood-based liquid biopsies for prostate cancer: clinical opportunities and challenges
por: Trujillo, Blanca, et al.
Publicado: (2022)

Review of Biomarkers in Ocular Matrices: Challenges and Opportunities
por: Tamhane, Mitalee, et al.
Publicado: (2019)

Analysis of PMEPA1 Isoforms (a and b) as Selective Inhibitors of Androgen and TGF-β Signaling Reveals Distinct Biological and Prognostic Features in Prostate Cancer
por: Sharad, Shashwat, et al.
Publicado: (2019)

Clinical Applications of Molecular Biomarkers in Prostate Cancer
por: Couñago, Felipe, et al.
Publicado: (2020)

Extracellular Vesicle as a Source of Alzheimer’s Biomarkers: Opportunities and Challenges
por: Lee, Seongju, et al.
Publicado: (2019)

Biomarkers: Opportunities and Challenges for Drug Development in the Current Regulatory Landscape
por: Gromova, Mariya, et al.
Publicado: (2020)

Cancer metastases: challenges and opportunities
por: Guan, Xiangming
Publicado: (2015)

Exploring Marine as a Rich Source of Bioactive Peptides: Challenges and Opportunities from Marine Pharmacology
por: Ahmed, Ishtiaq, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ht60n9rj53nsq5mu6ehtnrrq16